Mark VandenBranden
- Pharmacology top 0.05%
- Oncology top 2%
- Molecular Biology
- Pediatrics, Perinatology and Child Health top 2%
- Pharmacology top 2%
- Co-authors
- Steven WrightonBarbara J. RingStephen D. HallJeffrey StevensD. I. JonesJack GorskiS N BinkleyPaul B. Watkins
- Topics
- Pharmacogenetics and Drug Metabolism (26 papers)Drug Transport and Resistance Mechanisms (14 papers)Chemical Reactions and Isotopes (4 papers)
- Cited by
- PharmacologyOncologyTransplantation
- Journals
- Journal of Pharmacology and Experimental TherapeuticsArchives of Biochemistry and BiophysicsBiochemical Pharmacology
- Partner nations
- United StatesUnited KingdomBelgium
In The Last Decade
Mark VandenBranden
28 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 106
- Pharmacology 2.4k
- Oncology 1.3k
- Molecular Biology 615
- Pediatrics, Perinatology and Child Health 492
- Pharmacology 361
Countries citing papers authored by Mark VandenBranden
This map shows the geographic impact of Mark VandenBranden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark VandenBranden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark VandenBranden more than expected).
Fields of papers citing papers by Mark VandenBranden
This network shows the impact of papers produced by Mark VandenBranden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark VandenBranden. The network helps show where Mark VandenBranden may publish in the future.
Co-authorship network of co-authors of Mark VandenBranden
This figure shows the co-authorship network connecting the top 25 collaborators of Mark VandenBranden. A scholar is included among the top collaborators of Mark VandenBranden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark VandenBranden. Mark VandenBranden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 68 | |
| 3 | 53 | |
| 4 | 72 | |
| 5 | 106 | |
| 6 | 9 | |
| 7 | 81 | |
| 8 | 139 | |
| 9 | 93 | |
| 10 | 75 | |
| 11 | 42 | |
| 12 | 340 | |
| 13 | 252 | |
| 14 | 62 | |
| 15 | 146 | |
| 16 | 18 | |
| 17 | 7 | |
| 18 | 346 | |
| 19 | 69 | |
| 20 | 192 |
About Mark VandenBranden
Mark VandenBranden is a scholar working on Pharmacology, Pharmaceutical Science and Oncology, having authored 28 papers that have together received 3.1k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (26 papers), Drug Transport and Resistance Mechanisms (14 papers) and Chemical Reactions and Isotopes (4 papers). The work is most often cited by research in Pharmacology (2.4k citations), Oncology (1.3k citations) and Transplantation (104 citations). Mark VandenBranden has collaborated with scholars based in United States, United Kingdom and Belgium. Frequent co-authors include Steven Wrighton, Barbara J. Ring, Stephen D. Hall, Jeffrey Stevens, D. I. Jones, Jack Gorski, S N Binkley, Paul B. Watkins, Michael B. Fisher and Gerald W. Becker. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Archives of Biochemistry and Biophysics and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.